Credit rating
Company information
About HELMEDICA ApS
HELMEDICA ApS (CVR number: 28310374) is a company from AARHUS. The company recorded a gross profit of 53 kDKK in 2023. The operating profit was -11.5 kDKK, while net earnings were -39.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -2.4 %, which can be considered poor and Return on Equity (ROE) was -40.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 27.6 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. HELMEDICA ApS's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 153.64 | 21.35 | -44.00 | -17.91 | 53.00 |
EBIT | 92.47 | -26.77 | -81.16 | -56.12 | -11.54 |
Net earnings | 90.38 | -8.26 | -19.61 | -20.97 | -39.07 |
Shareholders equity total | 225.25 | 156.99 | 137.38 | 116.41 | 77.34 |
Balance sheet total (assets) | 340.98 | 384.93 | 289.46 | 295.11 | 280.32 |
Net debt | - 143.22 | -48.25 | -49.58 | -48.30 | -45.40 |
Profitability | |||||
EBIT-% | |||||
ROA | 41.6 % | -0.6 % | -5.5 % | -6.1 % | -2.4 % |
ROE | 48.8 % | -4.3 % | -13.3 % | -16.5 % | -40.3 % |
ROI | 47.2 % | -0.7 % | -6.2 % | -7.0 % | -2.8 % |
Economic value added (EVA) | 71.06 | -17.60 | -59.83 | -42.65 | -4.55 |
Solvency | |||||
Equity ratio | 66.1 % | 40.8 % | 47.5 % | 39.4 % | 27.6 % |
Gearing | 34.0 % | 126.4 % | 79.6 % | 120.7 % | 186.0 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 2.7 | 1.6 | 1.7 | 1.6 | 1.4 |
Current ratio | 2.7 | 1.6 | 1.7 | 1.6 | 1.4 |
Cash and cash equivalents | 219.74 | 246.66 | 158.97 | 188.86 | 189.22 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | B | B | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.